[Biological Sample Procurement Company iSpecimen Plans to Establish a $200 Million Digital Asset Reserve, Acquiring SOL via OTC] According to a report by Investing, as cited by Golden Finance, biological sample procurement company iSpecimen Inc. (ISPC) has announced that multiple cryptocurrency companies have approached them with investment opportunities. The company is planning to establish a $200 million digital asset reserve aimed at diversifying its balance sheet and supporting growth plans through tokenized real-world assets and top-ranking cryptocurrencies. iSpecimen is continuing parallel discussions to develop a financial plan based on the Solana blockchain. The company plans to purchase SOL through over-the-counter (OTC) transactions with cryptocurrency institutions, including locked SOL with contract transfers or vesting restrictions.